The Smoking Cessation Market Size is valued at 25380.0 Million in 2022 and is predicted to reach 53408.9 Million by the year 2031 at a 10.1 % CAGR during the forecast period for 2023-2031.
Key Industry Insights & Findings from the Report:
Cigarette smoking is the most significant single cause of illness and premature death globally. Worldwide, tobacco kills 7 million people every year. Almost a million deaths are due to non-smokers being exposed to second-hand smoke. Smoking cessation is the process of ceasing tobacco smoking. It is among one of the dynamic markets and is expected for exponential growth despite the economic conditions. Both prescription and over-the-counter products are available in the market.
The key drivers of the smoking cessation market include increasing tobacco consumption population, awareness amongst smokers on hazards of smoking, banning of tobacco product advertisement in many countries. Strict governmental regulations are emphasized to control the toxic effects on cardiac and respiratory systems. As a step forward, smoking is banned in public places, and high taxes are implemented on tobacco products and massive support to the cessation therapies. The major challenge faced by the market is the side effects of the drugs.
The market of smoking cessation is segmented based on various factors like product type, geography, end-users. Based on cessation aids, it is split by type NRT inhaler, NRT patch, spray, drug electronic cigarettes. Based on end-user, the market is segmented by application pharmacy, supermarket, hospital, other. Based on region, it is segmented as North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, Europe, Middle East & Africa. Due to increased awareness and government programs, APAC can be predicted as a profitable market.
In spite of available OTC and prescribed products, a robust pipeline of drugs is developed by several vendors. Monotherapy products that are already in the market are tested for combination therapy to reach better and rapid therapeutic targets.
Some of the products in the pipeline include X-22 Smoking Cessation Product of 22nd Century Limited is in phase 2; SELA-070, SEL-068 of Selecta Biosciences, Inc., is in phase 1 clinical trials. Despite failed results, unique products such as vaccines are also being investigated by researchers to curb smoking addiction.
|
Report Attribute |
Specifications |
|
Market Size Value In 2022 |
USD 25380.0 Million |
|
Revenue Forecast In 2031 |
USD 53408.9 Million |
|
Growth Rate CAGR |
CAGR of 10.1 % from 2023 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Million and CAGR from 2023 to 2031 |
|
Historic Year |
2019 to 2022 |
|
Forecast Year |
2023-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Products, By End-Users |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
|
Competitive Landscape |
Reckitt Benckiser, Pfizer, GlaxoSmithKline, Roche, Novartis, Johnson and Johnson, Bayer, Cipla, Takeda Pharmaceuticals, Sanofi, Selecta Biosciences, 22nd Century Limited, Fertin Pharma, Achieve Life Sciences, McNeil AB, and Others. |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing and Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Smoking Cession Market Snapshot
Chapter 4. Global Smoking Cession Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Products Estimates & Trend Analysis
5.1. By Products & Market Share, 2022 & 2030
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2030 for the following By Products:
5.2.1. Smoking Cessation Therapy Products
5.2.1.1. Nicotine Lozenges
5.2.1.2. Nicotine Gums
5.2.1.3. Nicotine Sprays
5.2.1.4. Nicotine Transdermal Patches
5.2.2. Drug Therapy
5.2.2.1. Zyban (Bupropion)
5.2.2.2. Chantix (varenicline)
5.2.3. Nicotine Sublingual Tablets
5.2.4. Nicotine Inhalers
5.2.5. E-cigarettes
Chapter 6. Market Segmentation 2: By End-User Estimates & Trend Analysis
6.1. By End-User & Market Share, 2022& 2030
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2030 for the following By End-User:
6.2.1. Application pharmacy
6.2.2. Supermarket
6.2.3. Hospital
Chapter 7. Smoking Cession Market Segmentation 3: Regional Estimates & Trend Analysis
7.1. North America
7.1.1. North America Smoking Cession Market revenue (US$ Million) estimates and forecasts By Products, 2022 - 2030
7.1.2. North America Smoking Cession Market revenue (US$ Million) estimates and forecasts By End-User, 2022 - 2030
7.1.3. North America Smoking Cession Market revenue (US$ Million) estimates and forecasts by country, 2022 - 2030
7.2. Europe
7.2.1. Europe Smoking Cession Market revenue (US$ Million) By Products, 2022 - 2030
7.2.2. Europe Smoking Cession Market revenue (US$ Million) estimates and forecasts By End-User, 2022 - 2030
7.2.3. Europe Smoking Cession Market revenue (US$ Million) by country, 2022 - 2030
7.3. Asia Pacific
7.3.1. Asia Pacific Smoking Cession Market revenue (US$ Million) By Products, 2022 - 2030
7.3.2. Asia Pacific Smoking Cession Market revenue (US$ Million) estimates and forecasts By End-User, 2022 - 2030
7.3.3. Asia Pacific Smoking Cession Market revenue (US$ Million) by country, 2022 - 2030
7.4. Latin America
7.4.1. Latin America Smoking Cession Market revenue (US$ Million) By Products, (US$ Million)
7.4.2. Latin America Smoking Cession Market revenue (US$ Million) estimates and forecasts By End-User, 2022 - 2030
7.4.3. Latin America Smoking Cession Market revenue (US$ Million) by country, (US$ Million) 2022 - 2030
7.5. Middle East & Africa
7.5.1. Middle East & Africa Smoking Cession Market revenue (US$ Million) By Products, (US$ Million)
7.5.2. Middle East & Africa Smoking Cession Market revenue (US$ Million) estimates and forecasts By End-User, 2022 - 2030
7.5.3. Middle East & Africa Smoking Cession Market revenue (US$ Million) by country, (US$ Million) 2022 - 2030
Chapter 8. Competitive Landscape
8.1. Major Mergers and Acquisitions/Strategic Alliances
8.2. Company Profiles
8.2.1. Reckitt Benckiser
8.2.2. Pfizer
8.2.3. GlaxoSmithKline
8.2.4. Novartis
8.2.5. Cipla
8.2.6. Takeda
8.2.7. Sanofi
8.2.8. Selecta Biosciences
8.2.9. Fertin Pharma
8.2.10. Other Prominent Player
Global Smoking Cession Market Outlook (Revenue, US$ Mn, 2019 – 2030) by Product
Global Smoking Cession Market Outlook (Revenue, US$ Mn, 2019 – 2030) by End-user
Global Smoking Cession Market Outlook (Revenue, US$ Mn, 2019 – 2030) By Region
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
